Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA-Reference-Cited by-同舟云学术

Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA

Published:2018-03-16 Issue:2 Volume:365 Page:437-446
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Gamage Thomas F.^ORCID,Farquhar Charlotte E.,Lefever Timothy W.,Marusich Julie A.,Kevin Richard C.,McGregor Iain S.,Wiley Jenny L.,Thomas Brian F.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference63 articles.

1. “Zombie” outbreak caused by the synthetic cannabinoid AMB-FUBINACA in New York;Adams;N Engl J Med,2017

2. Auwärter V Dargan P Wood D (2013) Synthetic cannabinoid receptor agonists, in Novel Psychoactive Substances Classification, Pharmacology and Toxicology ( Darga PI Wood DM eds), pp 317–343, Academic Press, Amsterdam.

3. Δ9-Tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication

4. The pharmacology of valinate and tert-leucinate synthetic cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and their analogues;Banister;ACS Chem Neurosci,2016

5. Patterns of synthetic cannabinoid use in Australia

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of piperazine and antipsychotic co-exposures and CB1 blockade on the effects elicited by AMB-FUBINACA, a synthetic cannabinoid, in mice;European Journal of Pharmacology;2024-09

2. Potential Implications of Multi-Drug Exposure with Synthetic Cannabinoids: A Scoping Review of Human Case Studies;Psychoactives;2024-08-03

3. Characterization of binding kinetics and intracellular signaling of new psychoactive substances targeting cannabinoid receptor using transition-based reweighting method;2024-07-26

4. Characterization of binding kinetics and intracellular signaling of new psychoactive substances targeting cannabinoid receptor using transition-based reweighting method;2024-07-26

5. GPCR kinase subtype requirements for arrestin-2 and -3 translocation to the cannabinoid CB1 receptor and the consequences on G protein signalling;Biochemical Pharmacology;2024-06